Cargando…

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice

In a multicenter randomized double-blind study we demonstrated that Qiliqiangxin (QLQX), a traditional Chinese medicine, had a protective effect in heart failure patients. However, whether and via which mechanism QLQX attenuates cardiac remodeling after acute myocardial infarction (AMI) is still unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Lichan, Shen, Sutong, Fu, Siyi, Fang, Hongyi, Wang, Xiuzhi, Das, Saumya, Sluijter, Joost P. G., Rosenzweig, Anthony, Zhou, Yonglan, Kong, Xiangqing, Xiao, Junjie, Li, Xinli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648480/ https://www.ncbi.nlm.nih.gov/pubmed/25669146 http://dx.doi.org/10.1038/srep08374

Ejemplares similares

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Common Variants for Heart Failure
por: Shen, Shutong, et al.
Publicado: (2015)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Crucial Role of miR-433 in Regulating Cardiac Fibrosis
por: Tao, Lichan, et al.
Publicado: (2016)

Crucial Role of miR-433 in Regulating Cardiac Fibrosis: Erratum
por: Tao, Lichan, et al.
Publicado: (2021)

Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
por: Leung, Alice Yeuk Lan, et al.
Publicado: (2021)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1
por: Xiao, Junjie, et al.
Publicado: (2017)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

Genetic and Epigenetic Regulation Networks: Governing from Cardiovascular Development to Remodeling
por: Xiao, Junjie, et al.
Publicado: (2017)

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice
por: Ye, Yong, et al.
Publicado: (2015)

Gut microbiome mediates the protective effects of exercise after myocardial infarction
por: Zhou, Qiulian, et al.
Publicado: (2022)

A snapshot of genetic and epigenetic basis of arrhythmia and heart failure
por: Xiao, Junjie, et al.
Publicado: (2015)

Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy
por: Zhou, Junyang, et al.
Publicado: (2020)

Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
por: Yao, Wenming, et al.
Publicado: (2020)

Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction
por: Danielson, Kirsty M., et al.
Publicado: (2018)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury
por: Shi, Jing, et al.
Publicado: (2017)

Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart
por: Wei, Yidong, et al.
Publicado: (2012)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
por: Qin, Yating, et al.
Publicado: (2022)

Qiliqiangxin attenuates hypoxia‐induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF‐1α‐dependent glycolysis
por: Wang, Yanyan, et al.
Publicado: (2018)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
por: Zhou, Yufei, et al.
Publicado: (2021)

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction
por: Wang, Yanyan, et al.
Publicado: (2020)

Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat
por: Soraya, Hamid, et al.
Publicado: (2015)

Hypoxia training attenuates left ventricular remodeling in rabbit with myocardial infarction
por: Wan, Chun-Xiao, et al.
Publicado: (2014)

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach
por: Fu, Junzeng, et al.
Publicado: (2018)

Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis
por: Wang, Luyang, et al.
Publicado: (2023)

RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction
por: Enomoto, Daichi, et al.
Publicado: (2017)

Jaboticaba (Myrciaria jaboticaba) Attenuates Ventricular Remodeling after Myocardial Infarction in Rats
por: da Silva, Renata Candido, et al.
Publicado: (2022)

Qiliqiangxin Capsule Modulates Calcium Transients and Calcium Sparks in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Li, Yuxin, et al.
Publicado: (2022)

Targeting Inflammation after Myocardial Infarction: A Therapeutic Opportunity for Extracellular Vesicles?
por: Viola, Margarida, et al.
Publicado: (2021)

Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction
por: Tang, Xian-Liang, et al.
Publicado: (2011)

Exercise downregulates HIPK2 and HIPK2 inhibition protects against myocardial infarction
por: Zhou, Qiulian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0nboqims5l94e45f7mtu3018en